DHJJ Financial Advisors’s GSK GSK Stock Holding History

DHJJ Financial Advisors’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$166	Hold	3	–	–	﹤0.01%	1009
2025 Q4	$148	Hold	3	–	–	﹤0.01%	971
2025 Q3	$130	Hold	3	–	–	﹤0.01%	945
2025 Q2	$116	Hold	3	–	–	﹤0.01%	926
2025 Q1	$117	Hold	3	–	–	﹤0.01%	879
2024 Q4	$102	Hold	3	–	–	﹤0.01%	854
2024 Q3	$123	Hold	3	–	–	﹤0.01%	830
2024 Q2	$116	Hold	3	–	–	﹤0.01%	784
2024 Q1	$129	Hold	3	–	–	﹤0.01%	761
2023 Q4	$112	Buy	+3	New	+$108	﹤0.01%	760

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

DHJJ Financial Advisors's GSK Position: Q1 2026 in Review

DHJJ Financial Advisors held its GSK (GSK) position steady in Q1 2026 at 3 shares worth $166. The position accounts for ﹤0.01% of the portfolio, ranked #1009.

DHJJ Financial Advisors first reported a position in GSK in Q4 2023 and has held it in 10 quarters since. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

DHJJ Financial Advisors held 3 shares of GSK worth $166 as of Q1 2026.
DHJJ Financial Advisors left its GSK share count unchanged in Q1 2026.
GSK made up ﹤0.01% of DHJJ Financial Advisors's portfolio in Q1 2026, its #1009 holding.
DHJJ Financial Advisors first reported a position in GSK in Q4 2023 and has held it in 10 quarters since.
1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on DHJJ Financial Advisors's 13F filing for Q1 2026, filed 9 Apr 2026.